Medicskin Holdings Ltd
HKEX:8307
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medicskin Holdings Ltd
HKEX:8307
|
HK |
|
Aramark
NYSE:ARMK
|
US |
|
N
|
Neurizer Ltd
ASX:NRZ
|
AU |
Balance Sheet
Balance Sheet Decomposition
Medicskin Holdings Ltd
Medicskin Holdings Ltd
Balance Sheet
Medicskin Holdings Ltd
| Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
5
|
26
|
48
|
30
|
28
|
19
|
16
|
43
|
29
|
14
|
5
|
7
|
17
|
|
| Cash |
5
|
26
|
48
|
30
|
28
|
19
|
16
|
43
|
29
|
14
|
5
|
7
|
17
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Total Receivables |
8
|
5
|
4
|
1
|
2
|
2
|
2
|
1
|
2
|
1
|
2
|
5
|
2
|
|
| Accounts Receivables |
0
|
1
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Receivables |
8
|
5
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
4
|
2
|
|
| Inventory |
3
|
2
|
2
|
3
|
4
|
3
|
4
|
3
|
3
|
3
|
5
|
4
|
4
|
|
| Other Current Assets |
0
|
0
|
0
|
10
|
9
|
2
|
57
|
10
|
11
|
11
|
14
|
14
|
14
|
|
| Total Current Assets |
16
|
33
|
54
|
44
|
43
|
26
|
79
|
57
|
46
|
30
|
27
|
30
|
37
|
|
| PP&E Net |
6
|
5
|
4
|
5
|
56
|
53
|
6
|
18
|
11
|
24
|
17
|
10
|
18
|
|
| PP&E Gross |
6
|
5
|
4
|
0
|
0
|
53
|
6
|
18
|
11
|
24
|
17
|
10
|
18
|
|
| Accumulated Depreciation |
13
|
15
|
0
|
0
|
0
|
20
|
22
|
32
|
24
|
29
|
37
|
29
|
29
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Long-Term Assets |
1
|
2
|
0
|
4
|
3
|
2
|
3
|
3
|
2
|
2
|
3
|
0
|
0
|
|
| Total Assets |
23
N/A
|
40
+74%
|
58
+47%
|
54
-7%
|
101
+87%
|
80
-21%
|
88
+10%
|
78
-12%
|
59
-25%
|
57
-4%
|
46
-18%
|
40
-14%
|
57
+43%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
1
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
|
| Accrued Liabilities |
1
|
3
|
0
|
0
|
0
|
2
|
3
|
2
|
4
|
3
|
3
|
0
|
0
|
|
| Short-Term Debt |
9
|
18
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
6
|
7
|
7
|
6
|
5
|
|
| Other Current Liabilities |
5
|
8
|
7
|
16
|
18
|
16
|
30
|
32
|
28
|
20
|
22
|
25
|
28
|
|
| Total Current Liabilities |
16
|
29
|
11
|
16
|
18
|
19
|
33
|
42
|
38
|
30
|
29
|
32
|
43
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
12
|
5
|
0
|
9
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
5
|
3
|
3
|
3
|
3
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
17
N/A
|
29
+77%
|
11
-62%
|
16
+47%
|
19
+14%
|
19
+4%
|
30
+56%
|
42
+40%
|
35
-17%
|
39
+11%
|
33
-17%
|
29
-11%
|
53
+83%
|
|
| Equity | ||||||||||||||
| Common Stock |
0
|
0
|
4
|
4
|
5
|
5
|
5
|
5
|
4
|
4
|
4
|
4
|
4
|
|
| Retained Earnings |
6
|
10
|
12
|
34
|
78
|
7
|
2
|
1
|
0
|
4
|
10
|
3
|
9
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
48
|
51
|
32
|
20
|
10
|
10
|
10
|
10
|
|
| Total Equity |
6
N/A
|
10
+68%
|
47
+354%
|
38
-20%
|
83
+119%
|
61
-27%
|
58
-4%
|
35
-39%
|
23
-34%
|
17
-26%
|
14
-20%
|
11
-21%
|
4
-62%
|
|
| Total Liabilities & Equity |
23
N/A
|
40
+74%
|
58
+47%
|
54
-7%
|
101
+87%
|
80
-21%
|
88
+10%
|
78
-12%
|
59
-25%
|
57
-4%
|
46
-18%
|
40
-14%
|
57
+43%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
333
|
333
|
400
|
400
|
480
|
480
|
486
|
486
|
397
|
397
|
397
|
397
|
397
|
|